Metabolic Diseases

• 

  Subject Areas on Research

  • A ceramide-centric view of insulin resistance. 
  • A comparison of cardio-metabolic risk between the deficit and non-deficit subtypes of schizophrenia. 
  • A novel approach for measuring residential socioeconomic factors associated with cardiovascular and metabolic health. 
  • A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. 
  • ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. 
  • Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. 
  • American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. 
  • Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. 
  • Association between life-course socio-economic status and prevalence of cardio-metabolic risk ractors in five middle-income countries. 
  • Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. 
  • At the intersection of place, race, and health in Brazil: Residential segregation and cardio-metabolic risk factors in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). 
  • Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder. 
  • Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. 
  • Cardiometabolic Assessment, Diagnosis, and Treatment of Chronic Medical Illnesses During an Inpatient Psychiatric Hospitalization: Colocated Medical Care Versus Treatment as Usual. 
  • Cell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism. 
  • Ceramides as modulators of cellular and whole-body metabolism. 
  • Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. 
  • Coronary heart disease moderates the relationship of chronic stress with the metabolic syndrome. 
  • Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. 
  • De Novo Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome. 
  • Design, implementation, and evaluation of population-specific telehealth nursing services. 
  • Dietary Patterns among Asian Indians Living in the United States Have Distinct Metabolomic Profiles That Are Associated with Cardiometabolic Risk. 
  • Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature. 
  • EFFECT OF HYPERVITAMINOSIS A ON RAT PLASMA LIPIDS. 
  • Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis. 
  • Elucidating the role of plexin D1 in body fat distribution and susceptibility to metabolic disease using a zebrafish model system. 
  • Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review. 
  • Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. 
  • Family-directed umbilical cord blood banking. 
  • Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. 
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 
  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Interplay between lipids and branched-chain amino acids in development of insulin resistance. 
  • Isolated sulfite oxidase deficiency. 
  • Lactation and neonatal nutrition: defining and refining the critical questions. 
  • Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. 
  • Liver transplantation for pediatric metabolic disease. 
  • Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. 
  • Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys. 
  • Metabolic deterioration of the sedentary control group in clinical trials. 
  • Metabolic network failures in Alzheimer's disease: A biochemical road map. 
  • Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. 
  • Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure. 
  • Metabolomics and Metabolic Diseases: Where Do We Stand? 
  • Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. 
  • Mineral metabolism: confusion to clarity. 
  • Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation. 
  • Myelodysplasia and deficiency of uridine diphosphate-galactose 4-epimerase. 
  • Nephrolithiasis in identical twins: the impact of nature vs nurture. 
  • Offspring of patients with diabetes exhibit a clustering of psychosocial distress and inflammatory and metabolic risk factors. 
  • Pathology of inherited manganese transporter deficiency. 
  • Pediatric urolithiasis. 
  • Polycystic ovary syndrome: update on diagnosis and treatment. 
  • Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. 
  • Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases. 
  • Predictors of gastrostomy placement in children with inherited metabolic diseases treated by umbilical cord blood transplantation. 
  • Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. 
  • Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin. 
  • Quantifying cardiometabolic risk using modifiable non-self-reported risk factors. 
  • RAT PLASMA PHOSPHOLIPIDS IN HYPERVITAMINOSIS A. 
  • Race differences in the relation of vitamins A, C, E, and β-carotene to metabolic and inflammatory biomarkers. 
  • Retinal vascular imaging in early life: insights into processes and risk of cardiovascular disease. 
  • Retinal vascular manifestations of metabolic disorders. 
  • Reye's syndrome. Possible causes and pathogenetic pathways. 
  • Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. 
  • Social jetlag, obesity and metabolic disorder: investigation in a cohort study. 
  • Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. 
  • Systemic associations of dynamic retinal vessel analysis: a review of current literature. 
  • The beehive and the merry-go-round in mineral metabolism. 
  • The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. 
  • The practical evaluation and selective medical management of nephrolithiasis. 
  • Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis. 
  • Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. 
  • Vascular risk factors and cognitive decline among elderly male twins. 
  • [THE ENZYMES OF THE LEUKOCYTE.] 
• 

  Keywords of People

  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Dedert, Eric, Assistant Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine
  • Guan, Ziqiang, Research Professor in Biochemistry, Biochemistry
  • Parikh, Suhag H., Associate Professor of Pediatrics, Pediatrics, Blood and Marrow Transplantation
  • Preminger, Glenn Michael, James F. Glenn, M.D. Professor of Urology, Surgery
  • Svetkey, Laura Pat, Professor of Medicine, Medicine
  • Terrando, Niccolò, Associate Professor in Anesthesiology, Cell Biology